{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/haematological-cancers-recognition-referral/","result":{"data":{"firstChapter":{"id":"1b99cc60-959f-5937-a54d-248dd557eb06","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field e674baf8-31fb-43bb-bf7e-a08aa6334159 --><h1>Haematological cancers - recognition and referral: Summary</h1><!-- end field e674baf8-31fb-43bb-bf7e-a08aa6334159 -->","htmlStringContent":"<!-- begin item 82e5293f-fe92-4437-a1f4-f88c18faee54 --><!-- begin field 9c7ebbb3-306e-4bbb-85b4-f87ec85c166b --><ul><li>Leukaemia<ul><li>Symptoms include pallor, bruising, and infection.</li><li>Consider a very urgent full blood count (within 48 hours) to assess for leukaemia in adults with any of the following:<ul><li>Pallor.</li><li>Persistent fatigue.</li><li>Unexplained fever.</li><li>Unexplained persistent or recurrent infection.</li><li>Generalized lymphadenopathy.</li><li>Unexplained bruising.</li><li>Unexplained bleeding.</li><li>Unexplained petechiae.</li><li>Hepatosplenomegaly.</li></ul></li><li>Refer children and young people for immediate specialist assessment if they have unexplained petechiae or hepatosplenomegaly.</li><li>Offer a very urgent full blood count (within 48 hours) to assess for leukaemia in children and young people with any of the following:<ul><li>Pallor.</li><li>Persistent fatigue.</li><li>Unexplained fever.</li><li>Unexplained persistent infection.</li><li>Generalized lymphadenopathy.</li><li>Persistent or unexplained bone pain.</li><li>Unexplained bruising.</li><li>Unexplained bleeding.</li></ul></li></ul></li><li>Myeloma<ul><li>Features include bone pain, bone marrow failure, and complications such as kidney failure or thromboembolism.</li><li>Offer a full blood count, blood tests for calcium and plasma viscosity or erythrocyte sedimentation rate in people aged 60 years and over with persistent bone pain, particularly back pain, or unexplained fracture.</li><li>Offer very urgent protein electrophoresis and a Bence-Jones protein urine test (within 48 hours) in people aged 60 years and over with hypercalcaemia or leukopenia and a presentation that is consistent with possible myeloma.</li><li>Consider very urgent protein electrophoresis and a Bence-Jones protein urine test (within 48 hours) to assess for myeloma if the plasma viscosity or erythrocyte sedimentation rate and presentation are consistent with possible myeloma.</li><li>Refer people using a suspected cancer pathway referral (appointment within 2 weeks) if the results of protein electrophoresis or a Bence-Jones protein urine test suggest myeloma.</li></ul></li><li>Non-Hodgkin’s lymphoma<ul><li>Symptoms include lymphadenopathy, sometimes accompanied by fever, pruritus, weight loss, or night sweats.</li><li>Consider a suspected cancer pathway referral (appointment within 2 weeks) for non-Hodgkin's lymphoma in adults presenting with unexplained lymphadenopathy or splenomegaly. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss.</li><li>Consider a very urgent referral (appointment within 48 hours) for specialist assessment for non-Hodgkin's lymphoma in children and young people presenting with unexplained lymphadenopathy or splenomegaly. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss.</li></ul></li><li>Hodgkin’s lymphoma<ul><li>Symptoms include lymphadenopathy, sometimes accompanied by fever, pruritus, weight loss, or night sweats.</li><li>Consider a suspected cancer pathway referral (appointment within 2 weeks) for Hodgkin's lymphoma in adults presenting with unexplained lymphadenopathy. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, weight loss, or alcohol-induced lymph node pain.</li><li>Consider a very urgent referral (appointment within 48 hours) for specialist assessment for Hodgkin's lymphoma in children and young people presenting with unexplained lymphadenopathy. When considering referral, take into account any associated symptoms, particularly fever, night sweats, shortness of breath, pruritus, or weight loss.</li></ul></li></ul><!-- end field 9c7ebbb3-306e-4bbb-85b4-f87ec85c166b --><!-- end item 82e5293f-fe92-4437-a1f4-f88c18faee54 -->","topic":{"id":"7a666688-628e-59c5-9e49-275e6df96c89","topicId":"efd78d5c-f39b-47aa-a99a-712fcd440511","topicName":"Haematological cancers - recognition and referral","slug":"haematological-cancers-recognition-referral","aliases":[],"chapters":[{"id":"1b99cc60-959f-5937-a54d-248dd557eb06","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"f3b3ad5d-37b7-5a29-8e71-51338dfd53d0","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"77a57871-2fdc-584c-9148-924a40f28c72","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"1b4978ef-a636-510a-b98b-df2c1d638607","slug":"changes","fullItemName":"Changes"},{"id":"31156ad7-e1ac-50f7-a238-d5ab91d07500","slug":"update","fullItemName":"Update"}]},{"id":"dfef533d-7728-5775-8f82-3e745c90c505","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"388024d8-7d15-587b-8988-d7c628863b80","slug":"goals","fullItemName":"Goals"},{"id":"c513e6cc-f297-57a6-adef-8b1e4f1f8f2c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7e3cb3e7-e51c-5962-8394-f4e0a6813935","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3aaac357-49bc-50e7-9bc7-f68a75f8f23b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f422ee8f-401a-55f0-af2e-ec46fece5aba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7a906314-79dc-5a14-86d9-f6c963dbfaf0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0205c796-921c-5df9-aa6e-52892106204f","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"0075cdde-2c8e-5e7d-9734-e640651b657b","slug":"presentation","fullItemName":"Presentation"},{"id":"76cd470e-5904-5537-8ec0-73d5a2425747","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0fbae03d-8109-54c7-ad40-6ad26a3ae1b4","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"399985ab-242f-53f8-8852-45b946548d09","slug":"symptoms-suggestive-of-haematological-cancers","fullItemName":"Symptoms suggestive of haematological cancers"},{"id":"129bfa10-e11b-5bf8-aeac-2ec5de9171d7","slug":"investigations-in-primary-care","fullItemName":"Investigations in primary care"}]},{"id":"e4e9d509-0950-59c5-9f10-397475616fe8","slug":"management","fullItemName":"Management","subChapters":[{"id":"cfe47d3f-300b-5be4-b4da-3dd966fef722","slug":"referral-for-haematological-cancer","fullItemName":"Scenario: Referral for haematological cancer"}]},{"id":"61fcee5d-ff66-5a4c-91e7-4f497dfcc559","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"ae7d0bdc-fc33-577f-9cfe-009a08676afa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"f9e3a44b-54f7-5761-b0f1-43617129d77e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"13a9be84-5d20-5ab3-8ea3-6490e30776d4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e1c7b25a-a475-5f05-a2da-9d859d501051","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f9ed371b-e3f7-510a-a3f5-e7c55990b468","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ff05ddf2-8028-5120-8912-94378fd8dc5a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f7896863-2653-51f8-8deb-f8525add21d6","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"7a666688-628e-59c5-9e49-275e6df96c89","topicId":"efd78d5c-f39b-47aa-a99a-712fcd440511","topicName":"Haematological cancers - recognition and referral","slug":"haematological-cancers-recognition-referral","aliases":[],"topicSummary":"Leukaemia Symptoms include pallor, bruising and infection.","lastRevised":"Last revised in February 2021","nextPlannedReviewBy":"2025-08-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2025-07","nextPlannedReviewByDisplay":"July 2025","specialities":[{"id":"46239e57-7990-560a-810f-b31000558649","name":"Cancer","slug":"cancer"}],"chapters":[{"id":"1b99cc60-959f-5937-a54d-248dd557eb06","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"f3b3ad5d-37b7-5a29-8e71-51338dfd53d0","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"77a57871-2fdc-584c-9148-924a40f28c72","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"1b4978ef-a636-510a-b98b-df2c1d638607","slug":"changes","fullItemName":"Changes"},{"id":"31156ad7-e1ac-50f7-a238-d5ab91d07500","slug":"update","fullItemName":"Update"}]},{"id":"dfef533d-7728-5775-8f82-3e745c90c505","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"388024d8-7d15-587b-8988-d7c628863b80","slug":"goals","fullItemName":"Goals"},{"id":"c513e6cc-f297-57a6-adef-8b1e4f1f8f2c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7e3cb3e7-e51c-5962-8394-f4e0a6813935","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3aaac357-49bc-50e7-9bc7-f68a75f8f23b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f422ee8f-401a-55f0-af2e-ec46fece5aba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7a906314-79dc-5a14-86d9-f6c963dbfaf0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0205c796-921c-5df9-aa6e-52892106204f","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"0075cdde-2c8e-5e7d-9734-e640651b657b","slug":"presentation","fullItemName":"Presentation"},{"id":"76cd470e-5904-5537-8ec0-73d5a2425747","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0fbae03d-8109-54c7-ad40-6ad26a3ae1b4","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"399985ab-242f-53f8-8852-45b946548d09","slug":"symptoms-suggestive-of-haematological-cancers","fullItemName":"Symptoms suggestive of haematological cancers"},{"id":"129bfa10-e11b-5bf8-aeac-2ec5de9171d7","slug":"investigations-in-primary-care","fullItemName":"Investigations in primary care"}]},{"id":"e4e9d509-0950-59c5-9f10-397475616fe8","slug":"management","fullItemName":"Management","subChapters":[{"id":"cfe47d3f-300b-5be4-b4da-3dd966fef722","slug":"referral-for-haematological-cancer","fullItemName":"Scenario: Referral for haematological cancer"}]},{"id":"61fcee5d-ff66-5a4c-91e7-4f497dfcc559","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"ae7d0bdc-fc33-577f-9cfe-009a08676afa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"f9e3a44b-54f7-5761-b0f1-43617129d77e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"13a9be84-5d20-5ab3-8ea3-6490e30776d4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e1c7b25a-a475-5f05-a2da-9d859d501051","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f9ed371b-e3f7-510a-a3f5-e7c55990b468","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ff05ddf2-8028-5120-8912-94378fd8dc5a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f7896863-2653-51f8-8deb-f8525add21d6","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"7a666688-628e-59c5-9e49-275e6df96c89"}},"staticQueryHashes":["3666801979"]}